NASDAQ:RGNX | Free Cash Flow | REGENXBIO Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$76.19M$1.24M-$77.42M
2025-12-31-$52.29M$508,000.00-$52.8M
2025-03-31$33.63M$1.02M$32.61M536.00%
2024-12-31-$31.62M$1.08M-$32.7M
2024-03-31-$55.46M$557,000.00-$56.01M
2023-12-31-$40.76M$1.13M-$41.89M
2023-03-31-$80.92M$4.82M-$85.74M
2022-12-31-$39.37M$5.47M-$44.84M
2022-03-31-$55.91M$10.97M-$66.88M
2021-12-31$341.5M$14.61M$326.88M111.18%
2021-03-31-$44.05M$31.02M-$75.07M
2020-12-31$39.47M$12.89M$26.58M
2020-03-31-$35.57M$4.63M-$40.2M
2019-12-31-$25.51M$1.03M-$26.54M
2019-03-31-$29.3M$2.46M-$31.75M
2018-12-31-$4.14M$4.89M-$9.03M-209.68%
2018-03-31$58.13M$2.34M$55.79M53.52%
2017-12-31-$13.83M$2.1M-$15.93M
2017-03-31-$17.48M$2.93M-$20.41M
2016-12-31-$20.42M$4.44M-$24.86M
2016-03-31-$7.89M$416,000.00-$8.3M
2015-12-31-$4.44M$128,000.00-$4.57M
2015-03-31-$1.68M$106,000.00-$1.78M
2014-12-31$138,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$123.96M$2.41M-$126.38M
2024-12-31-$173.13M$2.44M-$175.56M
2023-12-31-$218.41M$9.96M-$228.37M
2022-12-31-$207.49M$30.72M-$238.21M
2021-12-31$218.88M$84.18M$134.7M105.37%
2020-12-31-$54.06M$26.87M-$80.93M
2019-12-31-$107.71M$11.72M-$119.43M
2018-12-31$104.65M$13.28M$91.37M91.43%
2017-12-31-$57.99M$7.16M-$65.15M
2016-12-31-$48.56M$8.15M-$56.71M
2015-12-31-$22.52M$522,000.00-$23.04M
2014-12-31-$2.4M
2013-12-31-$3.01M